For many pharmaceutical companies, use of contract manufacturing organisations (CMO) to package commercial products is...
Be4ward have announced it has helped produce a new guide, published by Pharma Logistics, answering critical questions surrounding the EU Falsified Medicines Directive (FMD) and its effects on pharmaceutical packaging.
The global pharmaceutical market faces unprecedented complexities and pressures regarding the packaging and labelling of medicinal products. The new guide examines the changes required for pharmaceutical packaging to meet the requirements of EU Falsified Medicines Directive (FMD) and the crucial questions to ask to achieve compliance. This guide includes areas such as EU FMD packaging related requirements, broader organisation and supply chain implications, unique identifiers (UID), anti-tampering solutions, and artwork design implementation guidance.
The guide was recently published by Pharma Logistics IQ for IQPC’s Pharmaceutical Packaging and Labelling Summit, which took place from 19 June to 21 June in Zurich, Switzerland. Be4ward led the creation of this guide, in partnership with Schawk and Patheon. Lead author of the guide and serialisation practice vice-president at Be4ward Stephen McIndoe explains: ‘We wanted this guide to be useful to companies who are still looking for help with their EU FMD serialisation project. This guide is aimed to provide an awareness of the crucial questions companies should be asking.’
Download your free copy of the EU FMD Artwork Compliance Guide here
Be4ward advises companies on how to accelerate the process to meet the fast-approaching EU FMD Artwork Compliance deadline. Be4ward has helped many pharmaceutical and biotechnology companies and their supply chain partners to define and implement end-to-end serialisation capabilities to both meet legislative requirements and deliver other business benefits. Be4ward also specialise in the areas of labelling and artwork, delivering value to its clients through a combination of deep subject matter expertise and excellent consulting skills.
Be4ward’s serialisation services include:
- Strategy development
- Ongoing legislation understanding and impact assessment
- Requirements development
- Independent solution supplier selection
- Detailed design
- Supply chain partner integration management
- Implementation support
- Validation services
- Support model design and implementation
- Project and program management
Be4ward is a niche consultancy company helping pharmaceutical, biotechnology, and medical device companies and their supply bases improve their serialisation, labelling, and artwork capabilities. Be4ward helps clients define the most efficient business processes, organisation design, and helps select and implement the most appropriate service providers and IT systems to meet their needs.
This WP is the second in a two-part whitepaper: 'Avoiding the Supply Risk From Serialisation...
Be4ward has announced it will be attending Making Pharmaceuticals Exhibition and Conference this year.The event...
Be4ward and rfXcel have recently co-hosted a successful, informative webinar addressing the 2017 DSCSA Serialization...